AEVEX (NYSE:AVEX) reported sharply higher first-quarter revenue and profitability in its first earnings call as a public company, citing strong execution on a large unmanned aerial systems program and rising demand for autonomous defense platforms.
Chief Executive Officer Roger Wells said the compa
CDW (NASDAQ:CDW) executives said customers are moving beyond artificial intelligence experimentation and are increasingly asking for help deploying AI “safely, economically, and at scale,” during a JPMorgan fireside chat featuring Chair and CEO Christine Leahy and CFO Albert Miralles.
Leahy said th
Urban Outfitters (NASDAQ:URBN) reported record first-quarter fiscal 2027 sales and earnings, with management pointing to broad strength across its retail brands, continued growth at Nuuly and a strong wholesale performance.
Chief Executive Officer Dick Hayne said net sales rose 11% to $1.5 billion
StepStone Group (NASDAQ:STEP) reported record fee-related earnings and fundraising in its fiscal fourth quarter 2026, even as GAAP results were weighed down by accounting related to its StepStone Private Wealth profits interests.
The private markets investment firm reported a GAAP net loss attribut
NVIDIA (NASDAQ:NVDA) reported record first-quarter fiscal 2027 results, with revenue, operating income and free cash flow all surpassing prior company highs, as executives said demand for AI infrastructure continued to accelerate across hyperscale cloud providers, AI cloud companies, sovereign custo
CCC Intelligent Solutions Holdings Inc. Common Stock (NASDAQ:CCC) management said the company is entering its next phase with artificial intelligence moving from evaluation and testing into broader production use across its customer base.
Speaking at the JPMorgan Boston TMC Conference, CEO Githesh
Biosig Technologies (NASDAQ:STEX), operating as Streamex Corp, said its first quarter of 2026 marked a transition from product preparation to early commercialization, highlighted by the launch of its tokenized gold product, the payment of initial dividends to holders and the retirement of its conver
e.l.f. Beauty (NYSE:ELF) reported what executives described as a seventh consecutive year of “industry-leading” results, with fiscal 2026 net sales up 25% and adjusted EBITDA up 13%, while also signaling a more cautious near-term outlook for its core e.l.f. brand.
Chairman and Chief Executive Offic
Belite Bio (NASDAQ:BLTE) said it has begun a rolling New Drug Application submission to the U.S. Food and Drug Administration for Tinlarebant in Stargardt disease, while also accelerating preparations for a potential commercial launch.
On the company’s first-quarter 2026 earnings call, Chairman and
Intuit (NASDAQ:INTU) reported fiscal third-quarter revenue growth of 10% and raised its full-year outlook, while management outlined plans to reduce the company’s full-time workforce by 17% and adjust its approach to lower-income, price-sensitive tax filers.
Chairman and CEO Sasan Goodarzi said the
